Compound News and Research

RSS

Novel method of drug delivery to inhibit the growth of prostate cancer cells

Prostate cancer is the second leading cause of cancer-related death for men in the U.S. Present treatments for metastatic prostate cancer (cancer cells that spread to other parts of the body) include hormonal therapy, chemotherapy and radiotherapy, which frequently have serious side effects.

23 Jun 2007

Arpida receives FDA approval to initiate Phase II trial with intravenous iclaprim

Arpida Ltd. has announced that it has received approval from the US Food and Drug Administration for a Phase II trial with intravenous iclaprim in the treatment of patients with hospital-acquired pneumonia (HAP), ventilator-associated pneumonia (VAP) or healthcare-associated pneumonia (HCAP) suspected or confirmed to be due to Gram-positive pathogens.

23 Jun 2007

New treatment slows the growth of colon and liver cancers

A. Navarro, a researcher at the School of Pharmacy of the University of Navarra, has developed a new treatment which slows the growth of colon and liver cancers.

23 Jun 2007

New way to increase stem cells in blood

Researchers at Children's Hospital Boston report finding a new way to increase stem cells in blood, suggesting a possible treatment to help patients who undergo chemotherapy or bone marrow transplant for leukemia and other cancers recover their immune function more quickly.

23 Jun 2007

Bristol-Myers Squibb granted NDA for ixabepilone

Bristol-Myers Squibb has announced that the U.S. Food and Drug Administration (FDA) has accepted, for filing and review, the New Drug Application (NDA) for the investigational compound ixabepilone, an epothilone B analog.

20 Jun 2007

New Rochester program to coordinate patient care, research for patients suffering with brain and spinal tumors

The University of Rochester Medical Center and its Department of Neurosurgery are establishing a new multidisciplinary program to coordinate patient care, research and community outreach efforts for patients suffering with brain and spinal tumors.

8 Jun 2007

In mice, drug protects against diabetes and atherosclerosis

Blocking a single protein with an experimental drug prevented and treated both type 2 diabetes and atherosclerosis in laboratory mice that had been fed unhealthy diets and were genetically predisposed to these common killers, according to an article published online in Nature.

8 Jun 2007

New practical weight loss solution for the obese

Millions of people the world over suffer today from obesity, yet there is no magic bullet that has yet provided a universally accepted solution.

8 Jun 2007

What causes Alzheimer's disease?

Researchers tied the accumulation of the toxic brain protein beta-amyloid to Alzheimer's disease, according to a study reported at the 54th Annual Meeting of SNM, the world's largest society for molecular imaging and nuclear medicine professionals.

5 Jun 2007

AMPAKINE drugs may provide protection from drug-induced respiratory depression

Drug-induced respiratory depression is a life-threatening condition caused by analgesic, hypnotic, and anesthesia medications.

5 Jun 2007

New strategy for treating rare muscle disease, kidney disorders

Based on clues provided by a study with transgenic mice, a research group at the National Human Genome Research Institute (NHGRI), part of the National Institutes of Health (NIH), has developed a strategy that will be tested as the first treatment for people with hereditary inclusion body myopathy (HIBM), a rare, degenerative muscle disease.

3 Jun 2007

Compound derived from creosote bush slows aging in mice

Aspirin didn't pan out. Neither did two other potential anti-aging agents.

3 Jun 2007

AIDS Healthcare and Government of Cambodia partner in new free AIDS clinic in Cambodia

AIDS Healthcare Foundation (AHF) has announced the opening of its newest free AIDS treatment clinic in this partnership: a clinic facility in the Koh Thum District, in Kandal Province, Cambodia.

3 Jun 2007

Ranbaxy successfully challenges Atorvastatin patents in Norway

Ranbaxy Laboratories Limited (RLL) announced that the Norwegian Appeals Court today handed down a favorable decision for Ranbaxy in its case against Pfizer, involving key Norwegian patents on Atorvastatin in Norway.

1 Jun 2007

New class of compounds shows promise for cancer treatment

A new class of compounds developed by two University of Kentucky researchers shows promise as a nontoxic treatment of some cancers previously treated with toxic chemotherapy, the researchers report.

30 May 2007

Natural chemical with memory-enhancing effects

A natural compound found in blueberries, tea, grapes, and cocoa enhances memory in mice, according to newly published research.

30 May 2007

Smart mice miss out on Alzheimer's

Scientists in the U.S. have managed to breed mice which lack the enzyme thought to be the culprit in Alzheimer's disease.

28 May 2007

New way of fortifying flour with iron helps combat anaemia

Researchers from Wageningen University, Unilever and Akzo Nobel will be making this known in the authoritative scientific journal, The Lancet, this week.

28 May 2007

FDA approves treatment for bacterial vaginosis

Mission Pharmacal has announced that the U.S. Food and Drug Administration (FDA) approved Tindamax (tinidazole) for the treatment of bacterial vaginosis (BV), the most common vaginal infection among women of childbearing age in the United States.

28 May 2007